The estimated Net Worth of Philipp Lang is at least $4.54 million dollars as of 26 April 2018. Philipp Lang owns over 651,212 units of Conformis stock worth over $854,951 and over the last 9 years Philipp sold CFMS stock worth over $3,688,457.
Philipp has made over 21 trades of the Conformis stock since 2016, according to the Form 4 filled with the SEC. Most recently Philipp sold 651,212 units of CFMS stock worth $898,673 on 26 April 2018.
The largest trade Philipp's ever made was selling 651,212 units of Conformis stock on 26 April 2018 worth over $898,673. On average, Philipp trades about 89,214 units every 30 days since 2015. As of 26 April 2018 Philipp still owns at least 378,297 units of Conformis stock.
You can see the complete history of Philipp Lang stock trades at the bottom of the page.
Philipp's mailing address filed with the SEC is C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD, MA, 01730.
Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang et Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: